Read More Pharma Industry News Oragenics, Lantern Bioworks forge partnership for replacement-therapy assets In a landmark collaboration, Oragenics, Inc. (NYSE American: OGEN) and Lantern Bioworks have sealed a groundbreaking partnership through… byPallavi MadhirajuOctober 1, 2023